Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin
The interactions of novel anti-cancer therapeutic agents with the different plasma and tissue components, specifically serum albumins, have lately gained considerable attention due to the significant influence of such interactions on the pharmacokinetics and/or -dynamics of this important class of t...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The Royal Society
2020-01-01
|
| Colección: | Royal Society Open Science |
| Materias: | |
| Acceso en línea: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsos.191595 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|